Pretend Ozempic within the US drug chain

In the course of the growing demand for GLP-1 medication for the therapy of diabetes and supporting weight reduction, the US Meals and Drug Administration (FDA) has revealed an pressing warning for shoppers with Ozempic. The company calls on customers to rigorously examine their remedy names after he has discovered that a whole lot of faux ozempic injections exterior the licensed US provide chain bear been circulated.

The FDA warning follows the affirmation of Novo Nordisk, the producer of Ozempic and the load loss remedy, that the US market had pretend for 1-milligram-Ozempic pencils. In response to this, the FDA confiscated the recognized pretend merchandise on April 9, 2025.

“The company recommends wholesalers, retail pharmacies, physician practitioners and sufferers to ascertain and never distribute the product you’ve gotten acquired, or to promote or promote, that are marked with the Los Quantity Nar0074 and the serial quantity 430834149057, as proven beneath. Some instances could also be obtainable. Press launchtogether with pictures of the pretend names as a reference.

In an replace revealed on Monday, the company continued to warn that further suspicious packaging will likely be conscious, particularly for “unfastened than Par0362 and serial numbers, beginning with the primary eight digits 51746517”.

Six undesirable occasions related to the individual involved bear already been reported, though no to be prompted instantly by the pretend product itself. All six incidents have been reported by Novo Nordisk, the producer of the drug, as piece of their ongoing monitoring efforts.

The FDA emphasised its dedication to fight pretend remedy and defined that it “takes stories about potential pretend merchandise severely”. The company works carefully with Novo Nordisk to be able to “determine, study and take away any suspected suspected injectable merchandise which can be present in the USA” as piece of an ongoing examination.

Meanwhile, medical specialists and shoppers are requested to report all unwanted side effects or hostile reactions which can be linked to Ozempic through his MedWatch safety data and this system for reporting on the undesirable occasion. Studies could be submitted on-line or by fax for a accomplished type to 1-800-FDA-0178. As well as, anybody who believes that the pretend or manipulated remedy, particularly on-line sellers, ought to contact their native coordinator of the FDA shopper complaints or report the exercise instantly through the FDA’s legal exercise portal.